Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPL | P06858 | 13/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 13/20 | 0.35 |
| ▸ | CA1 | P00915 | 5/20 | 0.32 |
| ▸ | CA2 | P00918 | 5/20 | 0.32 |
| ▸ | CA9 | Q16790 | 5/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA3 | P07451 | 1/20 | 0.30 |
| ▸ | CA4 | P22748 | 1/20 | 0.30 |
| ▸ | CA6 | P23280 | 1/20 | 0.30 |
| ▸ | CA5A | P35218 | 1/20 | 0.30 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14956695 | 0.80 | LPL (0.41) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL14956259 | 0.80 | LPL (0.40) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL23043819 | 0.79 | LPL (0.36) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL30032666 | 0.76 | LPL (0.35) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL24616359 | 0.76 | LPL (0.35) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL4789211 | 0.76 | LPL (0.42) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL24524492 | 0.76 | LPL (0.44) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL23043419 | 0.75 | CA1 (0.32) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL1335808 | 0.74 | LPL (0.41) | LPLLIPGCA1CA2CA9 | |
| SCHEMBL2204718 | 0.74 | LPL (0.41) | LPLLIPGCA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025123007-A1 | RAS INHIBITORS AND METHODS OF USE THEREOF | KESTREL THERAPEUTICS INC. (US) | 2025-06-12 | — | — | WO | disclosed |